|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Head and Neck Cancer | |||||
| Oropharynx Cancer | |||||
| Larynx Cancer | |||||
| Hypopharynx Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Head and Neck Neoplasms | |||||
| Hypopharyngeal Neoplasms | |||||
| Laryngeal Neoplasms | |||||
| Oropharyngeal Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Laryngeal Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Otorhinolaryngologic Diseases | |||||
| Otorhinolaryngologic Neoplasms | |||||
| Pharyngeal Diseases | |||||
| Pharyngeal Neoplasms | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Stomatognathic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Motexafin Gadolinium Injection | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Motexafin gadolinium | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Dermatologic Agents | |||||
| Pharmacologic Actions | |||||
| Photosensitizing Agents | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Pharmacyclics | |||||